chemoradiotherapy

You have access
Prognostic Factor of Severe Complications in Patients with Hypopharyngeal Cancer with Primary Concurrent Chemoradiotherapy
LIANG-YU CHEN, CHIA-CHANG HUANG, YUNG-AN TSOU, DA-TIAN BAU and MING-HSUI TSAI

Anticancer Research March 2015, 35 (3) 1735-1741;
You have access
Risk Factors for Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Chemoradiotherapy
KEISUKE TAMARI, FUMIAKI ISOHASHI, YUICHI AKINO, OSAMU SUZUKI, YUJI SEO, YASUO YOSHIOKA, YOSHITO HAYASHI, TSUTOMU NISHIDA, TETSUO TAKEHARA, MASAKI MORI, YUICHIRO DOKI and KAZUHIKO OGAWA

Anticancer Research December 2014, 34 (12) 7389-7393;
You have access
Chemoradiotherapy for Extrahepatic Bile Duct Cancer with Gross Residual Disease after Surgery
HAE JIN PARK, KYUBO KIM, EUI KYU CHIE, JIN-YOUNG JANG, SUN WHE KIM, SAE-WON HAN, DO-YOUN OH, SEOCK-AH IM, TAE-YOU KIM, YUNG-JUE BANG and SUNG W. HA

Anticancer Research November 2014, 34 (11) 6685-6690;
You have access
Predisposing Factors for Larynx Preservation Strategies with Non-surgical Multimodality Treatment for Locally Advanced (T3-4) Larynx, Hypopharynx and Cervical Esophageal Disease
GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, HIDEHIRO ETO, KOICHIRO MURAKI, CHIKAYUKI HATTORI, HIROHITO UMENO, NORIMITSU TANAKA, TOSHIAKI TANAKA, SATOAKI NAKAMURA and KEN YOSHIDA

Anticancer Research September 2014, 34 (9) 5205-5210;
You have access
Effects of Chemoradiotherapy on Lymph Nodes in Patients with Rectal Adenocarcinoma: Evaluation of Numbers and Sizes of Retrieved Lymph Nodes Inside and Outside the Radiation Field
KAZUTAKE OKADA, SOTARO SADAHIRO, TOSHIYUKI SUZUKI, AKIRA TANAKA, GOTA SAITO, AKEMI KAMIJO, TAKESHI AKIBA and SHUICHI KAWADA

Anticancer Research August 2014, 34 (8) 4195-4200;
You have access
Multimodal Approach for Cervical Esophageal Carcinoma: Role of Neoadjuvant Chemotherapy
GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, HIDEHIRO ETO, KOICHIRO MURAKI, CHIKAYUKI HATTORI, HIROHITO UMENO, TADASHI NAKASHIMA, TOSHIAKI TANAKA, SATOAKI NAKAMURA and KEN YOSHIDA

Anticancer Research April 2014, 34 (4) 1989-1992;
You have access
L-[3-¹⁸F]-α-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer
MAKOTO SOHDA, HIROAKI HONJYO, KEIGO HARA, DAIGO OZAWA, SHIGEMASA SUZUKI, NARITAKA TANAKA, AKIHIKO SANO, MAKOTO SAKAI, TAKEHIKO YOKOBORI, TAKANORI INOSE, TATSUYA MIYAZAKI, HITOSHI OJIMA, TETSUYA HIGUCHI, YOSHITO TSUSHIMA and HIROYUKI KUWANO

Anticancer Research February 2014, 34 (2) 909-913;
You have access
Non-surgical Multimodality Treatment for Locally Advanced (T3-4) Hypopharyngeal Cancer: The Impact of Pre-treatment Hemoglobin Level
GEN SUZUKI, ETSUYO OGO, TOSHI ABE, NAOFUMI HAYABUCHI, HIROHITO UMENO, TADASHI NAKASHIMA, HIDEYA YAMAZAKI, SATOAKI NAKAMURA and KEN YOSHIDA

Anticancer Research December 2013, 33 (12) 5561-5565;
You have access
C-Reactive Protein as Predictor of Recurrence in Patients with Rectal Cancer Undergoing Chemoradiotherapy Followed by Surgery
YUJI TOIYAMA, YASUHIRO INOUE, SUSUMU SAIGUSA, MIKIO KAWAMURA, AYA KAWAMOTO, YOSHINAGA OKUGAWA, JYUNICHIRO HIRO, KOJI TANAKA, YASUHIKO MOHRI and MASATO KUSUNOKI

Anticancer Research November 2013, 33 (11) 5065-5074;
You have access
Treatment Outcomes and Prognostic Factors for Thoracic Esophageal Cancer with Clinical Evidence of Adjacent Organ Invasion
YOICHI HAMAI, JUN HIHARA, MANABU EMI, JUNYA TAOMOTO, YOSHIRO AOKI, ICHIKO KISHIMOTO, YUTA IBUKI and MORIHITO OKADA

Anticancer Research August 2013, 33 (8) 3495-3502;

Main menu

User menu

Search

chemoradiotherapy

Pages